The PE Ratio as of December 2025 (TTM) for Elicera Therapeutics AB (publ) (ELIC.ST) is -22.38

According to Elicera Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -22.38. This represents a change of 116.59% compared to the average of -10.33 of the last 4 quarters.

Elicera Therapeutics AB (publ) (ELIC.ST) Historical PE Ratio (quarterly & annually)

How has ELIC.ST PE Ratio performed in the past?

The mean historical PE Ratio of Elicera Therapeutics AB (publ) over the last ten years is -5195.10. The current -22.38 PE Ratio has changed -56.92% with respect to the historical average. Over the past ten years (40 quarters), ELIC.ST's PE Ratio was at its highest in in the March 2024 quarter at -1.46. The PE Ratio was at its lowest in in the March 2020 quarter at -5862.16.

Elicera Therapeutics AB (publ) (ELIC.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Elicera Therapeutics AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Elicera Therapeutics AB (publ) (ELIC.ST) Average PE Ratio

How has ELIC.ST PE Ratio performed in the past?

The current PE Ratio of Elicera Therapeutics AB (publ) (ELIC.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Elicera Therapeutics AB (publ) (ELIC.ST) PE Ratio vs. Peers

How is ELIC.ST’s PE Ratio compared to its peers?

Elicera Therapeutics AB (publ)’s PE Ratio is less than Xintela AB (publ) (-4.22), less than Intervacc AB (publ) (-4.85), less than Ascelia Pharma AB (publ) (-3.97), less than Acarix AB (publ) (-6.63), less than Karolinska Development AB (publ) (-0.67), less than Mendus AB (publ) (-2.52), less than Bio-Works Technologies AB (publ) (-6.37), less than Nanexa AB (publ) (-7.60), less than Magle Chemoswed Holding AB (publ) (-13.59), less than Initiator Pharma A/S (-11.41),

Build a custom stock screener for Elicera Therapeutics AB (publ) (ELIC.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elicera Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elicera Therapeutics AB (publ) (ELIC.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elicera Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.